|
HS Code |
255882 |
| Chemical Name | 1-(2-Imidazol-1-Yl-Ethyl)-Piperazine |
| Molecular Formula | C9H16N4 |
| Molecular Weight | 180.25 g/mol |
| Cas Number | 132335-44-3 |
| Appearance | Off-white to pale yellow solid |
| Purity | Typically ≥98% |
| Solubility | Soluble in DMSO, methanol |
| Storage Temperature | Store at 2-8°C |
| Smiles | C1CN(CCN1)CCN2C=NC=N2 |
| Inchi | InChI=1S/C9H16N4/c1-3-11-4-2-12(1)7-8-13-6-5-10-9-13 |
| Synonyms | 2-(1-Piperazinyl)ethylimidazole |
As an accredited 1-(2-Imidazol-1-Yl-Ethyl)-Piperazine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Amber glass vial containing 5 grams of 1-(2-Imidazol-1-Yl-Ethyl)-Piperazine, securely sealed and labeled with chemical details and safety information. |
| Shipping | **Shipping for 1-(2-Imidazol-1-Yl-Ethyl)-Piperazine:** This chemical is securely packaged in compliance with relevant safety regulations. Temperature and moisture control may be applied based on stability requirements. All containers are clearly labeled and shipped via registered couriers, accompanied by required documentation, such as a Safety Data Sheet (SDS) and hazard classification if applicable. |
| Storage | Store 1-(2-Imidazol-1-yl-ethyl)-piperazine in a tightly closed container, in a cool, dry, well-ventilated area, away from incompatible substances such as strong oxidizers and acids. Protect from moisture and direct sunlight. Ensure the storage area is secure and clearly labeled. Use appropriate chemical safety practices, including secondary containment to prevent spills and accidental release. |
Applications of 1-(2-Imidazol-1-Yl-Ethyl)-Piperazine in Industrial ManufacturingAs a direct manufacturer of 1-(2-Imidazol-1-Yl-Ethyl)-Piperazine, we supply this advanced heterocyclic intermediate to established sectors that require precise formulation, validated production workflows, and regulatory-compliant raw materials. The following applications highlight authentic industrial use cases where our product serves as a key enabler in specialty synthesis, from API intermediates to functional resin modifiers. This section outlines specific scenarios with dedicated details on integration standards, formulation ratios, process points, and targeted end-products. 1. Pharmaceutical Intermediate for Antifungal APIsOur material is selected by active pharmaceutical ingredient producers as an intermediate in the synthesis of select triazole antifungal compounds. Downstream manufacturing leverages the unique imidazole and piperazine motifs to construct high-value pharmacophores, with careful attention to regulatory traceability and impurity control. The raw material enters multi-step organic synthesis, supporting consistent batch yields and meeting documentation requirements under pharmaceutical GMP environments. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Polymeric Resin Modifier in Specialty CoatingsAdvanced industrial coatings manufacturers require tailored additives to achieve precise mechanical, adhesion, and chemical resistance profiles for end-use resins. Our chemical serves as a monofunctional modifier, incorporated to introduce hydrophilic sites and cross-linking points within custom epoxy, polyurethane, or acrylic resins. Process engineers value the molecular interactions provided, impacting downstream film morphology and long-term stability of final cured layers. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Precursor in Agrochemical Synthesis (Fungicide Formulations)Major agrochemical synthesis plants employ this material as a heterocycle-building block in the production of novel azole-type fungicide actives. The molecule’s ability to serve as a bridge between imidazole and piperazine fragments proves valuable for constructing next-generation broad-spectrum crop protectants. Its integration is monitored for both impurity profiles and trace residue compliance throughout large-scale, multi-step reactions typical of industrial agricultural synthesis. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Intermediate for CNS-Active Pharmaceutical CompoundsCertain pharmaceutical innovators and contract manufacturing organizations employ our product as a precursor in the synthesis of central nervous system (CNS)-active agents. The dual nitrogen-containing scaffold enables critical sidechain elongation and heterocycle modifications during the elaboration of lead molecules for therapeutic classes addressing neurological indications. Regulatory-driven synthesis requires exhaustive in-process monitoring for genotoxic impurities and precise material accountability. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 1-(2-Imidazol-1-Yl-Ethyl)-Piperazine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
At the manufacturing floor, the qualities of a compound reveal themselves during every step of synthesis, purification, and packaging. With 1-(2-Imidazol-1-Yl-Ethyl)-Piperazine, we focus on a clean, reliable process. Over years of handling various heterocyclic intermediates, few offer quite the balance of processability and functionality as this molecule. Long before any paperwork or datasheet, the substance’s pyridine-like aroma blends with a trace of sharpness from the imidazole ring – a clear sign of the actual compound, rather than an impurity or degraded byproduct.
Its full name describes the structure: one piperazine ring, functionalized with a two-carbon linker capped by an imidazole group. Compared to the more common 1-(2-hydroxyethyl)-piperazine or simple piperazine derivatives, this modification opens up new options for downstream chemistries. With both nucleophilic and basic characteristics, the molecule responds differently under various temperature and pH conditions. From synthesis runs at kilogram scales to bulk crystallization tanks, our team tracks every yield, residue, and variance using proven analytical methods – not just by the book, but adjusted with each batch’s real attributes.
Our experience shows that the best way to judge a batch isn’t just by NMR and HPLC purity, though these remain essential. We work with practical measures, like the compound’s melting range, solubility in solvents like DMF and DMSO, and the distinctive way it recrystallizes from isopropanol-water mixtures. Minor variations in synthesis – from the grade of starting materials to the quality of catalyst – can subtly shift yield or particle size, which is why our teams check every lot with both direct chemical analysis and visual inspection. Batch-to-batch reproducibility means that project managers and formulation scientists can plan reliably, knowing the material won’t introduce headaches at the blending or reaction stage.
There’s a marked difference in reactivity when comparing this imidazole-functionalized piperazine to N-substituted piperazines like N-methylpiperazine or N-benzylpiperazine. The combination of the imidazole group and piperazine backbone affects both electron distribution and steric hindrance, giving medicinal chemists and organic researchers a tool that’s tuned for targeted modifications. From our end, attention goes into each filtration and purification stage, because even trace contaminants can cause a measurable drop in yield or selectivity in downstream coupling reactions.
End users often ask where this molecule fits into broader chemical synthesis. We commonly see orders from teams working in small-molecule pharmaceutical development, particularly in exploratory synthesis of kinase inhibitors and other bioactive compounds. The unique imidazole tail brings a hydrogen-bond donor and acceptor site, critical in fine-tuning drug-likeness or optimizing for enzyme binding. Our relationships with medicinal chemistry labs have shown us specific kinetic profiles that only arise with the (2-imidazol-1-yl-ethyl) link. Rather than a generic amine, the molecule offers a handle that resists unwanted oxidation, and stands up to a wider range of pH than simpler alkyl-piperazines.
For polymer and material science applications, our partners highlight the predictability of imidazole-based systems for designing pH sensors, chelating agents, and electronic devices. The molecule’s charge-delocalizing imidazole fragment, when tethered to piperazine, behaves differently compared to imidazole or piperazine alone. Teams working on surface-ligand attachment protocols consistently report fewer side reactions and easier purification. These feedback loops between laboratory and plant shape how we refine each process step, right down to degassing procedures and post-filtration drying parameters.
There’s no substitute for direct synthesis experience. Every kilogram of 1-(2-Imidazol-1-Yl-Ethyl)-Piperazine starts as a set of raw materials—sometimes coming in from multiple suppliers. Each shipment of imidazole and 2-chloroethylpiperazine undergoes both chemical and physical checks in our QC lab. As those components go into the reactor, process operators note the shift in reaction heat, the way crystallization progresses, and the ease (or stubbornness) of filtration. With years of hands-on experience, our team can detect off-batch odors or color shifts well before any number on a spec sheet.
Instead of overrelying on templated documents, our technical staff continually update batch records, noting real adjustments made to address specific bottlenecks. The solvent ratios, degassing times, even the grade of nitrogen purge, all get logged in ways that generic spec sheets would never capture. This attention to lived detail ensures our customers receive a product closely aligned to the actual chemical’s best behavior—not just its theoretical properties.
Scaling from bench to pilot and then to commercial batches pulls all variables into sharp focus. Early on, we learned that process temperature discipline makes the difference between a clean product and a tarry polymerized side stream. The imidazole ring, sensitive to acid or strong electrophiles, reacts unpredictably under uncontrolled conditions. Consistency in stirring, rate of addition, and time-at-temperature results in a dense, off-white crystalline solid ready for downstream uses. Over time, we’ve optimized purification to reliably control color, particle size, and moisture, because every variable will rear its head in the production environment downstream.
Few intermediates require such careful monitoring of water content. The unique hydrophilicity of both the imidazole and the piperazine motifs means residual solvent and moisture levels impact both handling and downstream performance. We still run straight Karl Fischer titrations on every batch, and won’t ship material if the water content sits above the low threshold needed for further coupling. Seasonal humidity changes sometimes force process tweaks, and it’s this kind of real-world challenge that can’t be finessed into a general description.
Laboratory teams working at the cutting-edge of pharmaceutical discovery have specific needs. Unlike standard commodities, this compound supports processes that demand not only general purity, but particular filterability, stability, and process safety under scale-up. Several partner labs have remarked on time saved at the purification stage due to our tight control of crystalline morphology and pre-filtering for extraneous particulates. Beyond laboratory chemistry, production-scale formulators appreciate batches that pour evenly, dissolve at expected rates, and require minimal pH adjustment before use.
Meanwhile, material science collaborators focus on processability in casting and coating applications. The amphiphilic balance conferred by the molecule’s dual-nitrogen rings becomes important in sensor surface design, where minor changes in compound purity can influence sensor drift or background current. Long-term, the only way to achieve trusted results is staying close to both the production line and the real-world applications pushing the science forward.
Proper handling starts with a well-sealed, light-protected container, because both imidazole and piperazine rings react over time with oxygen and light. A cool, dry store room and air-evacuated packaging keep product degradation below the threshold where changes in color or odor can signal incipient breakdown. Our experience shows that even minor moisture ingress or repeated package opening shortens shelf life. We advise prompt use once a vessel is opened and recommend minimizing headspace in storage containers to cut down on oxygen contact.
Disposal of residues or off-specification batches requires respect for both environmental controls and safety procedures. Direct incineration or chemical deactivation in acidified solutions is the preferred route, based on our own controlled waste-handling studies. Staff receive annual training, not only for compliance but for diligent day-to-day handling—to prevent safety lapses that the paperwork won’t catch.
The imidazole-ethyl functional group does more than just extend the molecule’s backbone. In recent development projects, users found that the electronic properties of the imidazole ring allow for tighter target binding and a broader spectrum of chemical reactivity. Unlike N-methylpiperazine, which operates as a straightforward base, or N-benzylpiperazine, often used for its steric bulk, our compound’s versatility makes it better suited for nuanced synthesis steps where multi-functionality matters. From our perspective, this translates to careful control of side reactions and minimization of salt byproducts.
In pilot projects for diagnostic reagents, the unique positioning of the imidazole versus simpler alkyl groups opened the door to more selective metal chelation and greater stability in harsh pH ranges. This tangible boost in stability—and the ease of purification that comes with it—results from direct hands-on tweaks in the purification protocol, developed through close work with academic partners and contract R&D teams.
As a core supplier for specialty chemicals, we have seen firsthand how a reliable batch of 1-(2-Imidazol-1-Yl-Ethyl)-Piperazine can keep research teams on deadline, avoid costly delays, and enable bolder experimental campaigns. Repeat customers have saved weeks by specifying bulk lots directly from the source, avoiding delivery gaps and property drift that sometimes show up in brokered or relabeled material. Our just-in-time logistics work not from a spreadsheet, but in tight collaboration between warehousing, QA, and the customer’s own project managers. The goal is clear: eliminate surprises that cascade through the supply chain.
For larger process campaigns, firms can request pre-shipment samples or batch records with each delivery. These aren’t generic certificates, but real logged details from that specific synthesis run, including any anomaly or modification. As process chemists ourselves, we know the time and frustration saved by early detection of an out-of-spec impurity level or an unexpected solubility shift. This kind of upstream transparency is the practical way to avoid headaches, delays, and lost opportunity downstream.
No process survives walled off from the people who actually run it. Our operators document everything from the smell of the off-gas during distillation to the rate of solidification in the final tank. That kind of granular detail—impossible to encapsulate in a broad product overview—forms the foundation for so many improvements made over successive batches. From recalibrating pH meters to troubleshooting sticky cake in the filter press, real-world skill and observation have pushed our process toward both better yield and fewer headaches for users.
Customers depend on us not just for shipment, but for troubleshooting odd behavior in their own process chemistry. We have worked through cases of unexpected reactivity, scale-up pressure drops, and unpredicted color in final products, not with phone trees or canned answers, but with practical advice based on hands-on experience. This extends product value far beyond the boundaries of our warehouse.
The past few years have taught every chemical manufacturer about the real costs of disrupted logistics and brittle sourcing. We hold alternative suppliers for every key raw material, qualifying them with actual chemistry in our own reactors, not just in paper audits. As we plan expansions or shifts in production lines, the decision process happens alongside operators and QC technicians—people who have a direct stake in every adjustment, every shortcut, and every risk. Inventory for key components stays local, so that an unforeseen shutdown overseas doesn’t threaten customer deliveries.
For advanced intermediates like 1-(2-Imidazol-1-Yl-Ethyl)-Piperazine, we commit to transparency about lead times, and give real feedback about likely delivery dates based on batch cycle times, not wishful thinking. The honest approach has protected more projects than any marketing claim could. When pandemics, storms, or policy changes squeeze the raw materials pipeline, it’s deep familiarity with both our process and upstream suppliers that keeps our product flowing.
Working at the frontier of specialty chemistry means collaborating across a wide range of scientific and technical backgrounds. Whether it’s fine-tuning a synthetic pathway for a lead candidate or troubleshooting an unexplained anomaly, our technical support draws not from generic manuals, but from a bench-up understanding shaped by hundreds of batch runs and customer conversations. Analytical and scale-up advice draws on direct experience of both successes and near-misses.
Research projects, especially those in medicinal chemistry or advanced materials, sometimes run into unanticipated side reactions or inconsistent reactivity. Access to consistent, unadulterated material provides a baseline that reduces one major source of noise in R&D. As the direct manufacturer, we respond rapidly to inquiries about unusual behaviors—from solvation quirks to rare byproduct formation—drawing on the knowhow that comes only from producing, purifying, and shipping thousands of kilograms over years.
Handling and producing advanced amines and imidazole intermediates brings on genuine environmental responsibilities. Practical steps, from real-time emission monitoring to secondary containment and solvent recovery, find their place in our daily routines. Our waste treatment isn’t theoretical or paper-based—it happens in dedicated reactors and scrubbers, managed by teams who know the hazards of poor disposal first-hand. While regulatory requirements set the baseline, years in this business have taught us that voluntary upgrades—like improved fume scrubbing or spent solvent recycling—pay for themselves both in regulatory uptime and lower neighborhood impact.
Staff input drives our safety and sustainability programs. Operators who catch process upsets or early signs of anomalous emissions can flag issues before they become problems. Direct communications between lab, plant, and management keep procedures relevant—not just box-ticking exercises. Over time, these habits shape the true footprint of a chemical operation, beyond what any compliance report claims.
Manufacturing 1-(2-Imidazol-1-Yl-Ethyl)-Piperazine requires more than following a recipe. The practical skill of a team steeped in chemical production delivers more value than any spec sheet. Each detail matters, from the starting material check to the last package closure. Our customers benefit from direct access to experience-driven production, focused technical support, and a supply chain that hasn’t drifted far from the realities of the chemical industry. Those seemingly minor choices at each step—solvent grade, drying technique, packaging seal—define the difference between frustration and effortless use. Trust in the source comes from this constant process, never from generic claims or relabeled stock.